Patents by Inventor Alan S. Krasner

Alan S. Krasner has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • USES OF A SOMATOSTATIN MODULATOR FOR THE TREATMENT OF DISEASE
    Publication number: 20220387420
    Abstract: Described herein are formulations of a somatostatin modulator, methods of making such formulations, and methods of using such formulations in the treatment of conditions, diseases, or disorders that would benefit from modulation of somatostatin activity.
    Type: Application
    Filed: May 24, 2022
    Publication date: December 8, 2022
    Inventors: Ajay MADAN, Sha Rosa LUO, Alan S. KRASNER
  • SOMATOSTATIN RECEPTOR TYPE 5 AGONIST FOR THE TREATMENT OF HYPERINSULINISM
    Publication number: 20220323427
    Abstract: Provided herein are methods and compositions for the treatment of hyperinsulinism
    Type: Application
    Filed: February 16, 2022
    Publication date: October 13, 2022
    Inventors: Christine FERRARA-COOK, Alan S. KRASNER
  • MELANOCORTIN SUBTYPE-2 RECEPTOR (MC2R) ANTAGONIST FOR THE TREATMENT OF DISEASE
    Publication number: 20220313691
    Abstract: Provided herein are methods and compositions for the treatment of diseases of ACTH excess, such as Cushing's disease, ectopic ACTH syndrome, and congenital adrenal hyperplasia.
    Type: Application
    Filed: March 16, 2022
    Publication date: October 6, 2022
    Inventors: Christine FERRARA-COOK, Alan S. KRASNER
  • Method of preventing type 2 diabetes with aerosolized insulin
    Publication number: 20020164267
    Abstract: Inhaled insulin can be used to prevent the progression of beta cell failure in Type 2 diabetes, thereby slowing the onset, or by stopping the onset indefinitely, or ameliorating the disease in patients in whom it is already established.
    Type: Application
    Filed: April 30, 2002
    Publication date: November 7, 2002
    Inventor: Alan S. Krasner
  • Use of glycogen phosphorylase inhibitors to inhibit tumor growth
    Publication number: 20020123513
    Abstract: This invention relates to the use of glycogen phosphorylase inhibitors of Formula I or Formula IA: 1
    Type: Application
    Filed: July 31, 2001
    Publication date: September 5, 2002
    Inventor: Alan S. Krasner